![[110] Stimulants for ADHD in children: Revisited](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/05/110-150x150.png)
This Letter reviews our previous publications and research on this topic and explores whether our publications have led to a change in prescribing of stimulants to children in BC. Despite concerns, stimulant drug treatment of childhood … Read More
What’s New
![[Oct 25-26] TI Course in Nanaimo: Save the Date!](https://www.ti.ubc.ca/wordpress/wp-content/themes/therapeutics-init/images/ti_ce.png)
[Oct 25-26] TI Course in Nanaimo: Save the Date!
Therapeutics Initiative Conference: Using Evidence Practically - offered in collaboration with the Nanaimo Division of Family Practice WHEN: Thursday, October 25 & Friday, October 26, 2018. WHERE: Dorchester Hotel: 70 Church St, … Read More
[Oct 27] TI Course in Surrey: Save the Date!
Best Evidence for Clinicians: Annual UBC Therapeutics Initiative Course WHEN: Saturday, October 27, 2018 – full day course 08:00 - 18:00 WHERE: Surrey Memorial Hospital in Surrey, BC [map] Overview Join us for this popular … Read More
![[109] Inhaled long acting β2 agonists for COPD](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/02/109-150x150.png)
[109] Inhaled long acting β2 agonists for COPD
In Therapeutics Letter #1021 we reviewed the inhaled long acting β2 agonist (LABA) indacaterol for chronic obstructive pulmonary disease (COPD). We concluded “There are no proven clinically meaningful benefits in terms of reduction in mortality or … Read More
![[108] Drugs to avoid](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/01/108-150x150.png)
[108] Drugs to avoid
In two previous Therapeutics Letters we presented Clinical Pearls from Prescrire International.1,2 Prescrire is one of a small number of drug bulletins in the world, which reports on prescription drugs and is completely independent of industry … Read More
Join the Conversation
The pressure of Big Pharma
"A Globe and Mail analysis found financial conflicts of interest are commonplace in clinical practice guidelines. As 10 major Canadian pharmaceutical players prepare to release their total payments to physicians, some prominent doctors are dismissing the limited disclosure as meaningless..."
#drugsafety #ptsafety #cpgs #guidelines #clinicalpracticeguidelines #clinicians #prescribers #researchethics
Cochrane Canada
The pressure of Big Pharma: Financial conflicts of interest common on medical guideline panels
theglobeandmail.com
As 10 major Canadian pharmaceutical players prepare to release their total payments to physicians, some prominent doctor...
